Osaic Holdings’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
VPM
VCM
RRAM
Osaic Holdings's HAE Position: Q1 2026 in Review
Osaic Holdings increased its Haemonetics (HAE) stake by 80% in Q1 2026, buying an estimated $8.6K and bringing the position to 298 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5964.
Osaic Holdings first reported a position in HAE in Q1 2020 and has held it in 24 quarters since. The position peaked at $225K in Q4 2020. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Osaic Holdings held 298 shares of Haemonetics worth $16.8K as of Q1 2026.
- Osaic Holdings bought 132 Haemonetics shares in Q1 2026, an estimated $8.6K.
- Haemonetics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5964 holding.
- Osaic Holdings first reported a position in Haemonetics in Q1 2020 and has held it in 24 quarters since.
- Osaic Holdings's Haemonetics position peaked at $225K in Q4 2020.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.